Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Long-Term Efficacy of Oral Vancomycin Prophylaxis for the Prevention of Clostridium difficile Recurrence.

Knight EM, Schiller DS, Fulman MK, Rastogi R.

J Pharm Pract. 2019 Feb 11:897190019825994. doi: 10.1177/0897190019825994. [Epub ahead of print]

PMID:
30744479
2.

Aicardi syndrome: epilepsy surgery as a palliative treatment option for selected patients and pathological findings.

Podkorytova I, Gupta A, Wyllie E, Moosa A, Bingaman W, Prayson R, Knight EM.

Epileptic Disord. 2016 Dec 1;18(4):431-439. doi: 10.1684/epd.2016.0872.

3.

Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.

Knight EM, Kim SH, Kottwitz JC, Hatami A, Albay R, Suzuki A, Lublin A, Alberini CM, Klein WL, Szabo P, Relkin NR, Ehrlich M, Glabe CG, Gandy S, Steele JW.

Neurol Neuroimmunol Neuroinflamm. 2016 May 10;3(3):e237. doi: 10.1212/NXI.0000000000000237. eCollection 2016 Jun.

4.

Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.

Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, Klein WL, Attie AD, Buettner C, Ehrlich ME, Gandy S.

Acta Neuropathol Commun. 2016 Feb 25;4:16. doi: 10.1186/s40478-016-0282-y.

5.

WAVEFORM WINDOW #32: 14 and 6 Hz Positive Spikes: A Normal Variant that Could be Mistaken as Epileptiform.

Eber C, de Bruyn G, Knight EM.

Neurodiagn J. 2015 Sep;55(3):204-10. No abstract available.

PMID:
26630813
6.

Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ.

Knight EM, Williams HN, Stevens AC, Kim SH, Kottwitz JC, Morant AD, Steele JW, Klein WL, Yanagisawa K, Boyd RE, Lockhart DJ, Sjoberg ER, Ehrlich ME, Wustman BA, Gandy S.

Mol Psychiatry. 2015 Feb;20(1):109-17. doi: 10.1038/mp.2014.135. Epub 2014 Oct 28.

7.

Paroxysmal non-epileptic events in infants and toddlers: A phenomenologic analysis.

Chen L, Knight EM, Tuxhorn I, Shahid A, Lüders HO.

Psychiatry Clin Neurosci. 2015 Jun;69(6):351-9. doi: 10.1111/pcn.12245. Epub 2014 Dec 1.

8.

Immunomodulation and AD--down but not out.

Knight EM, Gandy S.

J Clin Immunol. 2014 Jul;34 Suppl 1:S70-3. doi: 10.1007/s10875-014-0039-y. Epub 2014 Apr 30. Review.

PMID:
24781637
9.

High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.

Knight EM, Martins IV, Gümüsgöz S, Allan SM, Lawrence CB.

Neurobiol Aging. 2014 Aug;35(8):1821-32. doi: 10.1016/j.neurobiolaging.2014.02.010. Epub 2014 Feb 15.

10.

Genome-scale reconstruction of the sigma factor network in Escherichia coli: topology and functional states.

Cho BK, Kim D, Knight EM, Zengler K, Palsson BO.

BMC Biol. 2014 Jan 24;12:4. doi: 10.1186/1741-7007-12-4.

11.

Reduction of synaptojanin 1 accelerates Aβ clearance and attenuates cognitive deterioration in an Alzheimer mouse model.

Zhu L, Zhong M, Zhao J, Rhee H, Caesar I, Knight EM, Volpicelli-Daley L, Bustos V, Netzer W, Liu L, Lucast L, Ehrlich ME, Robakis NK, Gandy SE, Cai D.

J Biol Chem. 2013 Nov 1;288(44):32050-63. doi: 10.1074/jbc.M113.504365. Epub 2013 Sep 19.

12.

Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.

Knight EM, Brown TM, Gümüsgöz S, Smith JC, Waters EJ, Allan SM, Lawrence CB.

Dis Model Mech. 2013 Jan;6(1):160-70. doi: 10.1242/dmm.010173. Epub 2012 Aug 3.

13.

Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.

Vaca GF, Lenz T, Knight EM, Tuxhorn I.

Epileptic Disord. 2012 Jun;14(2):155-8. doi: 10.1684/epd.2012.0501.

14.

Obese mice exhibit an altered behavioural and inflammatory response to lipopolysaccharide.

Lawrence CB, Brough D, Knight EM.

Dis Model Mech. 2012 Sep;5(5):649-59. doi: 10.1242/dmm.009068. Epub 2012 Feb 10.

15.

Detailing the optimality of photosynthesis in cyanobacteria through systems biology analysis.

Nogales J, Gudmundsson S, Knight EM, Palsson BO, Thiele I.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2678-83. doi: 10.1073/pnas.1117907109. Epub 2012 Jan 30.

16.

Rapid doubling of Alzheimer's amyloid-β40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution.

Kim SH, Knight EM, Saunders EL, Cuevas AK, Popovech M, Chen LC, Gandy S.

F1000Res. 2012 Dec 21;1:70. doi: 10.12688/f1000research.1-70.v1. eCollection 2012.

17.

Nurse staffing and inpatient hospital mortality.

Knight EM.

N Engl J Med. 2011 Jun 23;364(25):2468-9; author reply 2469. doi: 10.1056/NEJMc1104381. No abstract available.

PMID:
21696319
18.

Genetic basis of growth adaptation of Escherichia coli after deletion of pgi, a major metabolic gene.

Charusanti P, Conrad TM, Knight EM, Venkataraman K, Fong NL, Xie B, Gao Y, Palsson BØ.

PLoS Genet. 2010 Nov 4;6(11):e1001186. doi: 10.1371/journal.pgen.1001186.

19.

RNA polymerase mutants found through adaptive evolution reprogram Escherichia coli for optimal growth in minimal media.

Conrad TM, Frazier M, Joyce AR, Cho BK, Knight EM, Lewis NE, Landick R, Palsson BØ.

Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20500-5. doi: 10.1073/pnas.0911253107. Epub 2010 Nov 5.

20.

Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease.

Knight EM, Verkhratsky A, Luckman SM, Allan SM, Lawrence CB.

Neurobiol Aging. 2012 Jan;33(1):187-93. doi: 10.1016/j.neurobiolaging.2010.02.003. Epub 2010 Mar 31.

PMID:
20359775
21.

The transcription unit architecture of the Escherichia coli genome.

Cho BK, Zengler K, Qiu Y, Park YS, Knight EM, Barrett CL, Gao Y, Palsson BØ.

Nat Biotechnol. 2009 Nov;27(11):1043-9. doi: 10.1038/nbt.1582. Epub 2009 Nov 1.

22.

Gene expression profiling and the use of genome-scale in silico models of Escherichia coli for analysis: providing context for content.

Lewis NE, Cho BK, Knight EM, Palsson BO.

J Bacteriol. 2009 Jun;191(11):3437-44. doi: 10.1128/JB.00034-09. Epub 2009 Apr 10. Review. No abstract available.

23.

Genome-scale reconstruction of the Lrp regulatory network in Escherichia coli.

Cho BK, Barrett CL, Knight EM, Park YS, Palsson BØ.

Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19462-7. doi: 10.1073/pnas.0807227105. Epub 2008 Dec 3.

24.

Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.

Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A.

PLoS One. 2008 Aug 13;3(8):e2935. doi: 10.1371/journal.pone.0002935.

25.

Genomewide identification of protein binding locations using chromatin immunoprecipitation coupled with microarray.

Cho BK, Knight EM, Palsson BØ.

Methods Mol Biol. 2008;439:131-45. doi: 10.1007/978-1-59745-188-8_9.

PMID:
18370100
26.

Genome-wide analysis of Fis binding in Escherichia coli indicates a causative role for A-/AT-tracts.

Cho BK, Knight EM, Barrett CL, Palsson BØ.

Genome Res. 2008 Jun;18(6):900-10. doi: 10.1101/gr.070276.107. Epub 2008 Mar 13.

27.

Systems approach to refining genome annotation.

Reed JL, Patel TR, Chen KH, Joyce AR, Applebee MK, Herring CD, Bui OT, Knight EM, Fong SS, Palsson BO.

Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17480-4. Epub 2006 Nov 6.

28.

Transcriptional regulation of the fad regulon genes of Escherichia coli by ArcA.

Cho BK, Knight EM, Palsson BØ.

Microbiology. 2006 Aug;152(Pt 8):2207-19.

PMID:
16849788
29.

The case for accurate and complete physician documentation.

Knight EM.

J S C Med Assoc. 2005 Oct;101(9):322-4.

PMID:
16494214
30.

PCR-based tandem epitope tagging system for Escherichia coli genome engineering.

Cho BK, Knight EM, Palsson BO.

Biotechniques. 2006 Jan;40(1):67-72.

31.

Unintended consequences.

Knight EM.

Ann Intern Med. 2005 Dec 20;143(12):917; author reply 917-8. No abstract available.

PMID:
16365477
32.

In silico design and adaptive evolution of Escherichia coli for production of lactic acid.

Fong SS, Burgard AP, Herring CD, Knight EM, Blattner FR, Maranas CD, Palsson BO.

Biotechnol Bioeng. 2005 Sep 5;91(5):643-8.

PMID:
15962337
33.

Integrating high-throughput and computational data elucidates bacterial networks.

Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO.

Nature. 2004 May 6;429(6987):92-6.

PMID:
15129285
34.

Interpatient variability: genetic predisposition and other genetic factors.

West WL, Knight EM, Pradhan S, Hinds TS.

J Clin Pharmacol. 1997 Jul;37(7):635-48. Review.

PMID:
9243358
35.

Carotenoids and retinoids: a review of research, clinical, and public health applications.

Hinds TS, West WL, Knight EM.

J Clin Pharmacol. 1997 Jul;37(7):551-8. Review.

PMID:
9243347
36.

C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation.

Bloch EF, Knight EM, Carmon T, McDonald-Pinkett S, Carter J, Boomer A, Ogunfusika M, Petersen M, Famakin B, Aniagolu J, Walker J, Gant R, Walters CS, Gaither TA.

Immunol Invest. 1997 Jun;26(4):409-19.

PMID:
9246562
37.

The effect of caffeine on pregnancy outcome variables.

Hinds TS, West WL, Knight EM, Harland BF.

Nutr Rev. 1996 Jul;54(7):203-7. Review.

PMID:
8918140
38.

Prenatal substance abuse and pregnancy outcomes among African American women.

Oyemade UJ, Cole OJ, Johnson AA, Knight EM, Westney OE, Laryea H, Hill G, Cannon E, Fomufod A, Westney LS.

J Nutr. 1994 Jun;124(6 Suppl):994S-999S. doi: 10.1093/jn/124.suppl_6.994S.

PMID:
8201451
39.

Nutrition, genital tract infection, hematologic values, and premature rupture of membranes among African American Women.

Westney OE, Westney LS, Johnson AA, Knight EM, Oyemade UJ, Cole OJ, Laryea H, Spurlock B, Manning M, Hiza HB.

J Nutr. 1994 Jun;124(6 Suppl):987S-993S. doi: 10.1093/jn/124.suppl_6.987S.

PMID:
8201450
40.

Maternal low level lead and pregnancy outcomes.

West WL, Knight EM, Edwards CH, Manning M, Spurlock B, James H, Johnson AA, Oyemade UJ, Cole OJ, Westney OE.

J Nutr. 1994 Jun;124(6 Suppl):981S-986S. doi: 10.1093/jn/124.suppl_6.981S.

PMID:
8201449
41.

Relationships of serum illicit drug concentrations during pregnancy to maternal nutritional status.

Knight EM, James H, Edwards CH, Spurlock BG, Oyemade UJ, Johnson AA, West WL, Cole OJ, Westney LS, Westney OE.

J Nutr. 1994 Jun;124(6 Suppl):973S-980S. doi: 10.1093/jn/124.suppl_6.973S.

PMID:
8201448
42.

Selected lifestyle practices in urban African American women--relationships to pregnancy outcome, dietary intakes and anthropometric measurements.

Johnson AA, Knight EM, Edwards CH, Oyemade UJ, Cole OJ, Westney OE, Westney LS, Laryea H, Jones S.

J Nutr. 1994 Jun;124(6 Suppl):963S-972S. doi: 10.1093/jn/124.suppl_6.963S.

PMID:
8201447
43.

Pica in an urban environment.

Edwards CH, Johnson AA, Knight EM, Oyemade UJ, Cole OJ, Westney OE, Jones S, Laryea H, Westney LS.

J Nutr. 1994 Jun;124(6 Suppl):954S-962S. doi: 10.1093/jn/124.suppl_6.954S.

PMID:
8201446
44.

Biochemical profile of African American women during three trimesters of pregnancy and at delivery.

Knight EM, Spurlock BG, Edwards CH, Johnson AA, Oyemade UJ, Cole OJ, West WL, Manning M, James H, Laryea H.

J Nutr. 1994 Jun;124(6 Suppl):943S-953S. doi: 10.1093/jn/124.suppl_6.943S.

PMID:
8201445
45.

Dietary intakes, anthropometric measurements and pregnancy outcomes.

Johnson AA, Knight EM, Edwards CH, Oyemade UJ, Cole OJ, Westney OE, Westney LS, Laryea H, Jones S.

J Nutr. 1994 Jun;124(6 Suppl):936S-942S. doi: 10.1093/jn/124.suppl_6.936S.

PMID:
8201444
46.

Multiple factors as mediators of the reduced incidence of low birth weight in an urban clinic population.

Edwards CH, Knight EM, Johnson AA, Oyemade UJ, Cole OJ, Laryea H, Westney OE, Westney LS.

J Nutr. 1994 Jun;124(6 Suppl):927S-935S. doi: 10.1093/jn/124.suppl_6.927S.

PMID:
8201443
47.

Demographic profile, methodology, and biochemical correlates during the course of pregnancy.

Edwards CH, Knight EM, Johnson AA, Oyemade UJ, Cole OJ, Nolan G, Westney OE, West WL, Laryea H, Hilliard P.

J Nutr. 1994 Jun;124(6 Suppl):917S-926S. doi: 10.1093/jn/124.suppl_6.917S.

PMID:
8201442
48.

Maternal stress and pregnancy outcomes in a prenatal clinic population.

Edwards CH, Cole OJ, Oyemade UJ, Knight EM, Johnson AA, Westney OE, Laryea H, West W, Jones S, Westney LS.

J Nutr. 1994 Jun;124(6 Suppl):1006S-1021S. doi: 10.1093/jn/124.suppl_6.1006S.

PMID:
8201440
49.

Prenatal predictors of performance on the Brazelton Neonatal Behavioral Assessment Scale.

Oyemade UJ, Cole OJ, Johnson AA, Knight EM, Westney OE, Laryea H, Hill G, Cannon E, Fomufod A, Westney LS.

J Nutr. 1994 Jun;124(6 Suppl):1000S-1005S. doi: 10.1093/jn/124.suppl_6.1000S.

PMID:
8201439
50.

Deoxyribonucleic acid, ribonucleic acid, and protein in the placentas of normal and selected complicated pregnancies.

Nolan GH, Nahavandi M, Edwards CH, Knight EM, Johnson AA, Oyemade UJ, Cole OJ, Westney OE, Westney LS, Winborne D.

J Nutr. 1994 Jun;124(6 Suppl):1022S-1027S. doi: 10.1093/jn/124.suppl_6.1022S.

PMID:
7515414

Supplemental Content

Loading ...
Support Center